Stocks and InvestingStocks and Investing
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017
Thu, September 21, 2017
Wed, September 20, 2017
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017

Christopher Raymond Initiated (BMRN) at Buy on, Sep 14th, 2017


Published on 2024-10-25 22:48:08 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy on, Sep 14th, 2017.

Christopher has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $89 on, Thursday, July 27th, 2017


This is the rating of the analyst that currently disagrees with Christopher


  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy on, Thursday, August 17th, 2017